Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.
Wang Y, Zhang Y, Luo H, Wei W, Liu W, Wang W, Wu Y, Peng C, Ji Y, Zhang J, Zhu C, Bai W, Xia L, Lei H, Xu H, Yin L, Weng W, Yang L, Liu L, Zhou A, Wei Y, Zhu Q, Zhu W, Yang Y, Xu Z, Wu Y.
Wang Y, et al. Among authors: zhang j.
Acta Pharm Sin B. 2024 Dec;14(12):5235-5248. doi: 10.1016/j.apsb.2024.08.019. Epub 2024 Aug 28.
Acta Pharm Sin B. 2024.
PMID: 39807309
Free PMC article.